Strictureplasty for Crohn’s disease of the small bowel in the biologic era: long-term outcomes and risk factors for recurrence

2020 ◽  
Vol 24 (7) ◽  
pp. 711-720 ◽  
Author(s):  
M. Rottoli ◽  
M. Tanzanu ◽  
C. A. Manzo ◽  
M. L. Bacchi Reggiani ◽  
P. Gionchetti ◽  
...  
Keyword(s):  
Risk Factors ◽  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Long Term Outcomes ◽  
Risk Factors For Recurrence

scholarly journals P442 Strictureplasty for Crohn’s disease of the small bowel in the biological era: long-term outcomes and risk factors for site specific recurrence

2019 ◽  
Vol 13 (Supplement_1) ◽  
pp. S331-S332
Author(s):  
M Rottoli ◽  
C A Manzo ◽  
M Tanzanu ◽  
F Rizzello ◽  
P Gionchetti ◽  
...  
Keyword(s):  
Risk Factors ◽  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Long Term Outcomes ◽  
Site Specific

Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn’s Disease: A Hospital-Based Cohort Study

2016 ◽  
Vol 61 (7) ◽  
pp. 2060-2067 ◽  
Author(s):  
Sang Hyoung Park ◽  
Sung Wook Hwang ◽  
Min Seob Kwak ◽  
Wan Soo Kim ◽  
Jeong-Mi Lee ◽  
...  
Keyword(s):  
Cohort Study ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Infliximab Treatment ◽  
Long Term Outcomes ◽  
Korean Patients

scholarly journals P173 Predictors of long-term outcomes of perianal fistulizing Crohn's disease

2013 ◽  
Vol 7 ◽  
pp. S78
Author(s):  
B. Tchoundjeu ◽  
T. Rohou ◽  
G. Bouguen ◽  
D. Cuen ◽  
T. Wallenhorst ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Long Term Outcomes

scholarly journals Management of Crohn’s disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression

2021 ◽  
Vol 14 (3) ◽  
pp. e239404
Author(s):  
Clare Harris ◽  
Richard James Harris ◽  
Louise Downey ◽  
Markus Gwiggner
Keyword(s):  
Risk Factors ◽  
Inflammatory Bowel Disease ◽  
Patient Safety ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Nutritional Therapy ◽  
Interleukin 12 ◽  
Inflammatory Bowel ◽  
Term Maintenance

Active inflammatory bowel disease (IBD), combined immunosuppression and corticosteroid therapy have all been identified as risk factors for a poor outcome in COVID-19 infection. The management of patients with both COVID-19 infection and active IBD is therefore complex. We present the case of a 31-year-old patient with Crohn’s disease, on dual immunosuppression with infliximab and mercaptopurine presenting with inflammatory small bowel obstruction and COVID-19 infection. The case highlights the use of nutritional therapy, which remains underused in the management of adults with IBD, to manage his flare acutely. Following negative SARS-CoV-2 PCR testing and SARS-CoV-2 IgG testing confirming an antibody response, ustekinumab (anti-interleukin 12/23) was prescribed for long-term maintenance.

scholarly journals Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era

JGH Open ◽  
2020 ◽  
Author(s):  
Tanya Lee ◽  
Michael A Kamm ◽  
Sally Bell ◽  
Mark Lust ◽  
Steve Brown ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Long Term Outcomes

Long-term outcomes after elective ileocecal resection in children with active localized Crohn's disease—a multicenter European study

2015 ◽  
Vol 50 (10) ◽  
pp. 1630-1635 ◽  
Author(s):  
Iva Hojsak ◽  
Sanja Kolacek ◽  
Lars Folmer Hansen ◽  
Jiri Bronsky ◽  
Maija Piekkala ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Ileocecal Resection ◽  
European Study ◽  
Long Term Outcomes
Sign in / Sign up

Export Citation Format

Share Document